EZM0414 (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-136328-5MG | 5 mg | 647,00 | Add | |
| HY-136328-1ML | 10mM/1mL | 731,00 | Add | |
| HY-136328-10MG | 10 mg | 1'090,00 | Add | |
| HY-136328-25MG | 25 mg | 2'231,00 | Add | |
| HY-136328-50MG | 50 mg | 2'737,00 | Add | |
| HY-136328-100MG | 100 mg | 4'003,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
EZM0414 TFA is a potent, selective and orally active inhibitor of SETD2 which is a human histone methyltransferase. EZM0414 TFA has anti-proliferative effects[1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Epigenetics |
| Format | Solubility: DMSO : 200 mg/mL (ultrasonic);H2O : 6.67 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: Phase 1 |
| Purity | 99.42% |
| Molecular Formula | C24H30F4N4O4 |
| Molecular Weight | 514.51 |
| CAS-Number | 2411759-92-5 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
